Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash and restricted cash presented on our consolidated balance sheets to amounts shown in our combined and consolidated statements of cash flows:

	As of December 31,
	2023		2022		2021
	(in thousands)
Cash and cash equivalents	$	2,974	$	—	$	128,578
Restricted cash – current	261		8,000		—
Restricted cash – noncurrent	5,494		7,304		6,539
Total cash, cash equivalents and restricted cash	$	8,729	$	15,304	$	135,117

Schedule of Restricted Cash and Restricted Cash Equivalents

The following table provides a reconciliation of cash and restricted cash presented on our consolidated balance sheets to amounts shown in our combined and consolidated statements of cash flows:

	As of December 31,
	2023		2022		2021
	(in thousands)
Cash and cash equivalents	$	2,974	$	—	$	128,578
Restricted cash – current	261		8,000		—
Restricted cash – noncurrent	5,494		7,304		6,539
Total cash, cash equivalents and restricted cash	$	8,729	$	15,304	$	135,117

Schedules of Concentration of Risk by Revenue

The below purchasers represented greater than 10% of our revenues during the years ended December 31, 2023, 2022 and 2021:

	2023	2022	2021
Shell Trading US Company	18.3%	20.8%	18.3%
ConocoPhillips	*	15.1%	*

*Purchaser did not account for greater than 10% of revenue for the year

Schedule of Goodwill

	Year Ended December 31,
	2023		2022
	(in thousands)
Balance at beginning of period	$	—	$	76,564
Additions	—		—
Measurement period adjustments	—		1,125
Impairment	—		(77,689)
Balance at end of period	$	—	$	—

Schedule of Supplemental Cash Flow

The following are our supplemental cash flow disclosures for the years ended December 31, 2023, 2022 and 2021:

	Year Ended December 31,
	2023		2022		2021
	(in thousands)
Supplemental cash flow disclosures:
Interest paid, net of amounts capitalized	$	113,796	$	81,920	$	35,055
Income tax (refunds) payments	(1,391)		8,164		562
Non-cash investing and financing activities:
Capital expenditures included in accounts payable and accrued liabilities	83,841		92,518		47,173
Equity consideration for acquisitions, net of cash acquired	—		—		647,579
Right-of-use assets obtained in exchange for leases	29,624		13,343		8,573
April 2021 Exchange and December 2020 Exchange	—		—		62,051
Noncontrolling Interest Carve-out	—		—		(121,872)
Capitalized non-cash equity-based compensation	—		—		3,373